









Markets
/
Stocks
/
nasdaq-orgo
/

Organogenesis Holdings Inc

ORGO

View Detailed Chart

4.510USD

-0.110-2.38%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

572.11MMarket Cap

LossP/E TTM



Organogenesis Holdings Inc

4.510

-0.110-2.38%

Overview Company Financials

Financials

Intraday

30m

Today

-2.38%

5 Days

-10.34%

1 Month

+6.12%

6 Months

+32.26%

Year to Date

+40.94%

1 Year

+69.55%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 3 analysts

BUY

Current Rating

7.000

Target Price

55.21%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

552

Total

Median

Average

Company name

Ratings

Analysts

Organogenesis Holdings Inc

ORGO

CRISPR Therapeutics AG

CRSP

Intellia Therapeutics Inc

NTLA

Ionis Pharmaceuticals Inc

IONS

Exact Sciences Corp

EXAS

IQVIA Holdings Inc

IQV

...

111

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Neutral

Sell(5)

Neutral(4)

Buy(3)

Indicators

Sell(2)

Neutral(4)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.088

Neutral

RSI(14)

53.195

Neutral

STOCH(KDJ)(9,3,3)

33.406

Sell

ATR(14)

0.297

Low Volatility

CCI(14)

-36.707

Neutral

Williams %R

46.299

Neutral

TRIX(12,20)

1.119

Sell

StochRSI(14)

0.000

Oversold

Moving Average

Sell(3)

Neutral(0)

Buy(3)

Indicators

Value

Direction

MA5

4.716

Sell

MA10

4.772

Sell

MA20

4.574

Sell

MA50

3.773

Buy

MA100

4.091

Buy

MA200

3.825

Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Organogenesis Holdings Inc. is a regenerative medicine company focused on the development, manufacture and commercialization of solutions for the advanced wound care and surgical and sports medicine markets. It offers a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. Its advanced wound care products include Apligraf for the treatment of venous leg ulcers and diabetic foot ulcers (DFUs); Dermagraft for the treatment of DFUs; PuraPly AM as an antimicrobial barrier and native, cross-linked extracellular matrix scaffold for a variety of wound types; and Affinity, Novachor and NuShield placental allografts to address a variety of wound sizes and types. Sports Medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM and PuraPly SX for management of open wounds in the surgical setting.

Ticker SymbolORGO

CompanyOrganogenesis Holdings Inc

CEOMr. Gary S. Gillheeney, Sr.

Websitehttps://investors.organogenesis.com